Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
DHR

DHR - Danaher Corp Stock Price, Fair Value and News

$187.46+1.20 (+0.64%)
Delayed

44/100

DHR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

44/100

DHR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

DHR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DHR Price Action

Last 7 days

-4.1%

Last 30 days

-14.8%

Last 90 days

-17.2%

Trailing 12 Months

-8.1%

DHR RSI Chart

DHR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DHR Valuation

Market Cap

132.6B

Price/Earnings (Trailing)

36.68

Price/Sales (Trailing)

5.4

EV/EBITDA

27.24

Price/Free Cashflow

25.2

DHR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

DHR Fundamentals

DHR Revenue

Revenue (TTM)

24.6B

Rev. Growth (Yr)

4.59%

Rev. Growth (Qtr)

12.97%

DHR Earnings

Earnings (TTM)

3.6B

Earnings Growth (Yr)

10.22%

Earnings Growth (Qtr)

31.83%

DHR Profitability

EBT Margin

17.23%

Return on Equity

6.88%

Return on Assets

4.33%

Free Cashflow Yield

3.97%

DHR Investor Care

Buy Backs (1Y)

1.06%

Diluted EPS (TTM)

5.05

DHR Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202523.8B24.0B24.3B24.6B
202423.7B23.6B23.7B23.9B
202326.1B25.4B24.6B23.9B
202224.5B23.8B23.0B26.6B
202124.8B26.7B28.1B24.8B
202018.0B18.9B20.4B22.3B
201917.2B17.4B17.6B17.9B
201818.1B17.9B17.5B17.0B
201717.2B17.4B17.8B18.3B
201615.2B16.0B16.6B16.9B
201517.9B16.5B15.3B14.4B
201418.5B18.7B19.0B19.2B
201318.2B18.2B18.2B18.3B
201217.1B18.0B18.0B18.3B
201112.9B13.4B14.8B16.1B
Get all data in R, Python etc through our Historical Stock Data APIs

About Danaher Corp

DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.
 CEO
 WEBSITEdanaher.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES65535

Danaher Corp Frequently Asked Questions

DHR is the stock ticker symbol of Danaher Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Danaher Corp is 132.56 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, DHR's PE ratio (Price to Earnings) is 36.68 and Price to Sales (PS) ratio is 5.4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DHR PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Danaher Corp has provided 0.118 (multiply by 100 for percentage) rate of return.